APPOINTMENT ROUND UP: GlaxoSmithKline, Sanofi, Immune Design, Clinigen, Advaxis, Nanobiotix and Kite Pharma

This week's round up includes CEO appointments by GSK, who has appointed Brian McNamara CEO of the company's consumer unit, Clinigen and The Grünenthal Group; and executive appointments by Sanofi, where Alan Main has joined as executive vice president consumer healthcare global business unit, Immune Design, Advaxis, Kite Pharma and Bavarian Nordic.

Brian McNamara, head of Europe & Americas at GlaxoSmithKline PLC's Consumer Healthcare business, has been drafted in as Emma Walmsley's replacement as the latter leaves her role as chief exec of the consumer unit to become group CEO. McNamara will continue as a member of the board of the consumer healthcare joint venture with Novartis and will be based in the UK. He joined GSK's consumer health executive team in 2015 - previously he had been at Novartis AG for 11 years.

Sanofi has appointed Alan Main executive vice president consumer healthcare. He will be a member of the executive committee and lead a newly created consumer healthcare global business unit – effective Oct. 1, 2016

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Executives On The Move

More from Leadership